ArticleOncotarget2016

MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A.

Huiling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.